Cannabinoid Antagonists Reduced Morphine Tolerance but Also Reduced Antinociception in Rats

A rat study reported reduced expression of morphine tolerance with cannabinoid receptor antagonists, alongside reduced morphine antinociception. Less tolerance therefore did not automatically mean a stronger immediate therapeutic effect.

The study compared agonists and antagonists

Male rats underwent a short cumulative morphine regimen, followed by tail-flick and hot-plate testing. The experiment included CB1- and CB2-directed agonist and antagonist conditions. These compounds were pharmacological probes, rather than cannabis products tested in patients.

The outcomes moved in different directions

The supplied abstract reports that agonist conditions increased morphine antinociception and tolerance, while AM251 and JTE907 attenuated tolerance expression. Its conclusion also reports decreased morphine antinociception with the antagonist combination. Both parts are needed to avoid turning an adaptation result into a claim of uniformly improved pain relief.

Expression is a specific phase of tolerance

Testing the response after a tolerance-inducing regimen differs from demonstrating prevention of every underlying adaptation. A reduced potency shift or altered challenge response does not by itself establish sustained clinical benefit, reduced opioid consumption or fewer adverse effects.

The study raises a tradeoff that mechanistic summaries can otherwise hide. An intervention may change the measure called tolerance while also weakening the desired acute response. The abstract does not establish an optimal human treatment strategy or show that cannabinoid blockade safely prolongs opioid analgesia.

Related: interpreting cannabis tolerance claims.

Research cited

Altun A; Yildirim K; Ozdemir E; Bagcivan I; Gursoy S; Durmus N. Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists. The journal of physiological sciences : JPS (2015). doi:10.1007/s12576-015-0379-2. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Different Amygdala Findings Varied by Both Subregion and Recording Method

Apparently different cannabinoid effects within the central amygdala could not be assigned solely to anatomy when recording methods differed as well. A paper discussing its medial recordings identified this interpretive limit. The current experiment measured spontaneous transmission Varodayan and colleagues recorded spontaneous and miniature GABAergic currents from the medial subdivision…

Spread the love

Read Article: Different Amygdala Findings Varied by Both Subregion and Recording Method

CB1 and CB2 Antagonists Gave Different Answers for WIN’s Synaptic Effect

A drug capable of activating more than one cannabinoid receptor needs evidence identifying the receptor responsible for a particular effect. A rat amygdala experiment compared CB1 and CB2 antagonism rather than relying only on WIN55,212-2’s drug-class label. The agonist first reduced inhibitory-current frequency Varodayan and colleagues applied WIN to central-amygdala…

Spread the love

Read Article: CB1 and CB2 Antagonists Gave Different Answers for WIN’s Synaptic Effect

A Weaker Direct WIN Response Did Not Eliminate Its Interaction With Alcohol

After chronic alcohol exposure, an experimental cannabinoid agonist had a diminished direct effect on GABA release but still prevented an acute alcohol-related increase. Reduced sensitivity depended on which response was being examined. The direct agonist challenge was attenuated Varodayan and colleagues found that WIN55,212-2 reduced inhibitory-current frequency in alcohol-naive rat…

Spread the love

Read Article: A Weaker Direct WIN Response Did Not Eliminate Its Interaction With Alcohol

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us